• PDF / 123,181 Bytes
• 1 Pages / 623.591 x 841.847 pts Page_size
• 5 Downloads / 176 Views

DOWNLOAD

REPORT

1173-5503/10/0521-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

PharmacoEconomics & Outcomes News 10 Feb 2007 No. 521

1

Recommend Documents

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Gr

167 57 785KB

Follicular Lymphoma

167 92 2MB

Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab

167 34 722KB

Follicular Lymphoma Current Management and Novel Approaches

170 64 8MB

Follicular Lymphoma and Mantle Cell Lymphoma Pathobiology, Diagnosis

155 2 5MB

Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab withou

135 70 841KB

Maintenance Therapy

143 62 25MB

Is treating post-ACS depression worth it?

189 108 112KB

A case of irreversible bradycardia after rituximab therapy for diffuse large B-cell lymphoma

142 60 1MB

Lenalidomide: A Review in Previously Treated Follicular Lymphoma

150 40 879KB

Methadone Maintenance Therapy

165 69 57MB

Non-operating Room Anesthesia: Is It Worth the Risk?

177 73 240KB